Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Statistics in Medicine|February 13, 2021
Predicting study duration in clinical trials with a time-to-event endpointRyunosuke Machida, Yosuke Fujii, Takashi Sozu
Clinical Trials (London, England)|January 18, 2023
Clinical trial design and analysis for comparing three treatments with intra-individual right- and left-hand dataRyunosuke Machida, Kentaro Sakamaki, Aya Kuchiba
Statistics in Medicine|December 15, 2025
Dynamic Prediction of Analysis Timing in Clinical Trials Using Joint Models of Longitudinal and Time-to-Event DataRyunosuke Machida, Kentaro Sakamaki, Tomohiro Ohigashi, et al.
Japanese Journal of Clinical Oncology|August 24, 2024
A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology groupTomohiro Nishina, Narikazu Boku, Yukinori Kurokawa, et al.
Japanese Journal of Clinical Oncology|June 6, 2024
Real-world treatment trends for patients with advanced prostate cancer and renal cell carcinoma and their cost-a survey in JapanTakahiro Osawa, Keita Sasaki, Ryunosuke Machida, et al.
British Journal of Haematology|May 18, 2019
Possibility of a risk-adapted treatment strategy for untreated aggressive adult T-cell leukaemia-lymphoma (ATL) based on the ATL prognostic index: a supplementary analysis of the JCOG9801Kosuke Toyoda, Kunihiro Tsukasaki, Ryunosuke Machida, et al.
ESMO Open|April 12, 2020
Infection risk with PI3K-AKT-mTOR pathway inhibitors and immune checkpoint inhibitors in patients with advanced solid tumours in phase I clinical trialsYutaka Fujiwara, Aya Kuchiba, Takafumi Koyama, et al.
Japanese Journal of Clinical Oncology|March 30, 2022
Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trialTsutomu Kobayashi, Kazuhito Yamamoto, Yoshitoyo Kagami, et al.
Japanese Journal of Clinical Oncology|July 9, 2020
Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC)Yuya Sato, Takanobu Yamada, Takaki Yoshikawa, et al.
Japanese Journal of Clinical Oncology|February 25, 2025
Obinutuzumab maintenance versus observation for patients with newly diagnosed high tumor burden follicular lymphoma who achieved complete metabolic response after obinutuzumab plus bendamustine induction therapy: a multicenter, randomized, phase III study (JCOG2008, MAIN study)Tsutomu Kobayashi, Kenichi Ishizawa, Ryunosuke Machida, et al.
Pageof 8